-
Media Release
Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness
-
Media Release
Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage
-
Media Release
Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage
-
Media Release
Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease
-
Media Release
Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease
-
Media Release
Novartis pivotal data show children and adolescents with relapsing MS had an 82% lower relapse rate with fingolimod vs. interferon beta-1a
-
Media Release
Novartis pivotal data show children and adolescents with relapsing MS had an 82% lower relapse rate with fingolimod vs. interferon beta-1a
-
Media Release
Novartis collaborates with pop icon Cyndi Lauper to release new song in honor of World Psoriasis Day
-
Media Release
Novartis collaborates with pop icon Cyndi Lauper to release new song in honor of World Psoriasis Day
-
Media Release
Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)
-
Media Release
Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)
-
Media Release
Alcon DAILIES® teams up with US Olympians - world-class gymnast Laurie Hernandez and soccer star Tobin Heath - to launch the Invisible Edge campaign